Has John Dewitt received payments from drug or device companies?

Yes. Drug and device makers reported $220,517 in general payments to John Dewitt across 277 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Dewitt did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Dewitt come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Dewitt

Psychiatry · Aiken, SCNPI 1952497653

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $205,050 of the $220,517 with a category attached, or 93.0%. AbbVie accounts for 92.3% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $60,889 and has fallen 99.8% since, to $95 in 2025. Among psychiatry clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$220,517in general payments, 2019–2025

Across 277 payments — averaging $796.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$204K
Teva Pharmaceuticals USA, Inc.$11K
Vanda Pharmaceuticals Inc.$5K
Johnson & Johnson$123
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$69
Takeda Pharmaceuticals U.S.A., Inc.$37
plus $148 from 7 others

What the payments were for

Speaking & faculty fees$205,05093%
Travel & lodging$12,3656%
Food & beverage$3,0561%
Education$470%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	235	$203,571
Teva Pharmaceuticals USA, Inc.	19	$11,255
Vanda Pharmaceuticals Inc.	4	$5,314
Johnson & Johnson	8	$123
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$69
Takeda Pharmaceuticals U.S.A., Inc.	2	$37
Lundbeck LLC	1	$27
Otsuka America Pharmaceutical, Inc.	1	$27
Corium, LLC	1	$23
Neurocrine Biosciences, Inc.	1	$19
Axsome Therapeutics, Inc.	1	$19
Alkermes, Inc.	1	$18
Bausch Health US, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VRAYLAR$200,862
UZEDY$10,805
Fanapt$5,314
VIIBRYD$200

How this compares

$220,517 in reported general payments places this provider in the 95th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	14	$7,822

Paid to pharmacies, not to this prescriber.

Other psychiatry in Aiken

Brittany AlbrightMount Pleasant$691K
Veronica RidpathFlorence$364K
Jagdish ShahRock Hill$320K
Ricardo FermoCharleston$262K
Jeffrey StephensGreenville$195K
Robert RichardsGreenville$142K
Nikunjkumar ModiFlorence$133K
Jacobo MintzerCharleston$132K
Murray HonickMyrtle Beach$125K
Floyd SalleeCharleston$121K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →